Is Chamomile Sleep Quality Meta-Analysis safe?

Updated July 2026

Quick Answer

Chamomile Sleep Quality Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Background Aromatherapy has been proposed as a non-pharmacological adjunctive intervention in critical care settings; however, evidence regarding its effects on objective outcome measures remains inconclusive.

Key Takeaways

  • 01Background Aromatherapy has been proposed as a non-pharmacological adjunctive intervention in critical care settings; however, evidence regarding its effects on objective outcome measures remains inconclusive. [Moyano PA (2026)]
  • 02Contrary to our hypothesis, no studies measured biochemical stress markers such as cortisol or catecholamines, representing a significant gap in the evidence base. [Moyano PA (2026)]
  • 03A notable finding was the disparity between evidence certainty: high for anxiety reduction versus low/very low for physiological outcomes, highlighting inadequate control for ICU-specific confounders in existing trials. [Moyano PA (2026)]
  • 04This systematic review aimed to evaluate the effectiveness of aromatherapy in modulating objective physiological and biochemical markers in adult intensive care unit (ICU) patients. [Moyano PA (2026)]
The current Migaku evidence database contains 1 reusable source document for Chamomile Sleep Quality Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Background Aromatherapy has been proposed as a non-pharmacological adjunctive intervention in critical care settings; however, evidence regarding its effects on objective outcome measures remains inconclusive. [Moyano PA (2026); evidence level 1] - Contrary to our hypothesis, no studies measured biochemical stress markers such as cortisol or catecholamines, representing a significant gap in the evidence base. [Moyano PA (2026); evidence level 1] - A notable finding was the disparity between evidence certainty: high for anxiety reduction versus low/very low for physiological outcomes, highlighting inadequate control for ICU-specific confounders in existing trials. [Moyano PA (2026); evidence level 1] - This systematic review aimed to evaluate the effectiveness of aromatherapy in modulating objective physiological and biochemical markers in adult intensive care unit (ICU) patients. [Moyano PA (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effects of aromatherapy on objective physiological outcomes in adult ICU patients: a systematic review.